AnalystsInsight

Kenneth Newman (KeyBanc): Analyst Track Record and Price‑Target Accuracy

How often Kenneth Newman’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 526 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

What changed since Oct 12

Exent re-checks this page every day. Ratings appear 30 days after they are published; live calls are in Gems.

#671 rank (was #799)

Key takeaways

  • Kenneth Newman ranks #639 of 1,000 analysts in Exent’s scoring (4.7★).
  • 67.2% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 124 days; 70.5% of calls were up 12 months later.
  • Most‑covered stocks: ROK, URI, WCC, HRI.
  • Free on Exent: Kenneth Newman’s full record, with ratings 3 days after publication.

Kenneth Newman’s track record at a glance

Kenneth Newman of KeyBanc ranks #639 of the 1,000 analysts Exent scores, with a 4.7★ rating and a focus on industrials. Over a 7‑year lookback, 67.2% of Kenneth’s price targets were reached, 14.8 points above the 52.4% average across all analysts.

MetricKenneth NewmanAll analysts
Price‑target hit rate67.2%52.4%
Median days to hit target124 days91 days
Calls up after 12 months70.5%64.0%
Median 12‑month return of calls+16.9%+13.4%
Hit rate, last 2 years68.6%—
Average worst drop after a call−16.0%—
Ratings in the sample526—
Stocks covered23—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetKenneth Newman
Under 30 days2.3%
30–90 days31.8%
90–180 days34.1%
Over 180 days31.8%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Kenneth Newman covers most

StockRatings in the sample
ROK37
URI35
WCC34
HRI30
EMR29
AIT28
MSM27
FAST24

In the past year Kenneth’s ratings were 66% Buy, 34% Hold and 0% Sell.

Kenneth Newman’s latest ratings

DateStockActionRatingPrice target
Sep 10, 2026SUNBReiterated: BuyBuy$90.00
Aug 14, 2026AITReiterated: BuyBuy$420.00
Aug 7, 2026CGNXReiterated: BuyBuy$80.00
Aug 6, 2026SYMReiterated: BuyBuy$70.00
Aug 5, 2026EMRReiterated: BuyBuy$170.00
Aug 5, 2026ROKReiterated: BuyBuy$510.00
Aug 5, 2026ZBRAReiterated: BuyBuy$430.00
Aug 5, 2026GWWReiterated: HoldHold$0.00
Jul 31, 2026TRSReiterated: BuyBuy$45.00
Jul 31, 2026WCCReiterated: BuyBuy$415.00
Jul 29, 2026HRIReiterated: BuyBuy$185.00
Jul 24, 2026URIReiterated: BuyBuy$1350.00
  • Sep 10, 2026
    Stock
    SUNB
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $90.00
  • Aug 14, 2026
    Stock
    AIT
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $420.00
  • Aug 7, 2026
    Stock
    CGNX
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $80.00
  • Aug 6, 2026
    Stock
    SYM
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $70.00
  • Aug 5, 2026
    Stock
    EMR
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $170.00
  • Aug 5, 2026
    Stock
    ROK
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $510.00
  • Aug 5, 2026
    Stock
    ZBRA
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $430.00
  • Aug 5, 2026
    Stock
    GWW
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $0.00
  • Jul 31, 2026
    Stock
    TRS
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $45.00
  • Jul 31, 2026
    Stock
    WCC
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $415.00
  • Jul 29, 2026
    Stock
    HRI
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $185.00
  • Jul 24, 2026
    Stock
    URI
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $1350.00

Kenneth’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Kenneth Newman’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Kenneth Newman ranks #639 of 1,000 with a 4.7★ rating. 67.2% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 70.5% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Kenneth Newman’s success rate is 68.8% by the ranking source and 67.2% by Exent’s price-target hit-rate backtest, with a median of 124 days to reach a target.

Kenneth Newman (KeyBanc) covers 23 stocks, mostly in industrials. The most frequently rated are ROK, URI, WCC, HRI, EMR.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.